Published in Lipids on August 05, 2010
Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods (2001) 414.27
The peroxisome proliferator-activated receptor-gamma is a negative regulator of macrophage activation. Nature (1998) 13.58
MCP-1 contributes to macrophage infiltration into adipose tissue, insulin resistance, and hepatic steatosis in obesity. J Clin Invest (2006) 12.32
Atherosclerosis. the road ahead. Cell (2001) 11.88
How regulatory T cells work. Nat Rev Immunol (2008) 11.66
The many roles of chemokines and chemokine receptors in inflammation. N Engl J Med (2006) 10.99
PPAR-gamma agonists inhibit production of monocyte inflammatory cytokines. Nature (1998) 10.09
Absence of monocyte chemoattractant protein-1 reduces atherosclerosis in low density lipoprotein receptor-deficient mice. Mol Cell (1998) 7.46
A SUMOylation-dependent pathway mediates transrepression of inflammatory response genes by PPAR-gamma. Nature (2005) 6.83
Chemokines in the pathogenesis of vascular disease. Circ Res (2004) 4.64
Inflammation as a cardiovascular risk factor. Circulation (2004) 4.26
Scavenger receptors class A-I/II and CD36 are the principal receptors responsible for the uptake of modified low density lipoprotein leading to lipid loading in macrophages. J Biol Chem (2002) 4.17
Major dietary patterns are related to plasma concentrations of markers of inflammation and endothelial dysfunction. Am J Clin Nutr (2004) 3.61
LXRs control lipid-inducible expression of the apolipoprotein E gene in macrophages and adipocytes. Proc Natl Acad Sci U S A (2001) 3.29
Toll-like receptor-4 is expressed by macrophages in murine and human lipid-rich atherosclerotic plaques and upregulated by oxidized LDL. Circulation (2001) 3.15
The Tangier disease gene product ABC1 controls the cellular apolipoprotein-mediated lipid removal pathway. J Clin Invest (1999) 2.77
Scavenger receptors in atherosclerosis: beyond lipid uptake. Arterioscler Thromb Vasc Biol (2006) 2.76
27-hydroxycholesterol is an endogenous ligand for liver X receptor in cholesterol-loaded cells. J Biol Chem (2001) 2.27
Molecular cloning of the human ATP-binding cassette transporter 1 (hABC1): evidence for sterol-dependent regulation in macrophages. Biochem Biophys Res Commun (1999) 2.08
Dietary fatty acids affect plasma markers of inflammation in healthy men fed controlled diets: a randomized crossover study. Am J Clin Nutr (2004) 1.93
15d-PGJ2: the anti-inflammatory prostaglandin? Clin Immunol (2005) 1.92
Brachial artery vasodilator function and systemic inflammation in the Framingham Offspring Study. Circulation (2004) 1.84
Inflammation in atherosclerosis and implications for therapy. Circulation (2004) 1.71
Bone marrow-derived monocyte chemoattractant protein-1 receptor CCR2 is critical in angiotensin II-induced acceleration of atherosclerosis and aneurysm formation in hypercholesterolemic mice. Arterioscler Thromb Vasc Biol (2004) 1.70
Dietary monounsaturated fatty acids promote aortic atherosclerosis in LDL receptor-null, human ApoB100-overexpressing transgenic mice. Arterioscler Thromb Vasc Biol (1998) 1.67
In vivo evidence for a role of toll-like receptor 4 in the development of intimal lesions. Circulation (2002) 1.61
Diet induction of monocyte chemoattractant protein-1 and its impact on obesity. Obes Res (2005) 1.56
Lipopolysaccharide down regulates both scavenger receptor B1 and ATP binding cassette transporter A1 in RAW cells. Infect Immun (2002) 1.40
Unsaturated fatty acids suppress the expression of the ATP-binding cassette transporter G1 (ABCG1) and ABCA1 genes via an LXR/RXR responsive element. Atherosclerosis (2006) 1.33
Dietary factors that promote or retard inflammation. Arterioscler Thromb Vasc Biol (2006) 1.32
Elevated monocyte chemoattractant protein-1 serum levels in patients at risk for coronary artery disease. Circ J (2005) 1.31
Dietary intake of differently fed salmon; the influence on markers of human atherosclerosis. Eur J Clin Invest (2005) 1.30
Markers of inflammation and their clinical significance. Atheroscler Suppl (2005) 1.17
IL-6, TNF-alpha and atherosclerosis risk indicators in a healthy family population: the STANISLAS cohort. Atherosclerosis (2003) 1.16
Selective up-regulation of LXR-regulated genes ABCA1, ABCG1, and APOE in macrophages through increased endogenous synthesis of 24(S),25-epoxycholesterol. J Biol Chem (2006) 1.15
Plasma MCP-1 level and risk for peripheral arterial disease and incident coronary heart disease: Atherosclerosis Risk in Communities study. Atherosclerosis (2005) 1.15
Impact of simvastatin, niacin, and/or antioxidants on cholesterol metabolism in CAD patients with low HDL. J Lipid Res (2003) 1.13
Age-associated increase in PGE2 synthesis and COX activity in murine macrophages is reversed by vitamin E. Am J Physiol (1998) 1.11
Dietary fish oil reduces intercellular adhesion molecule 1 and scavenger receptor expression on murine macrophages. Atherosclerosis (2000) 1.11
Atherosclerosis and inflammation. Patterns of cytokine regulation in patients with peripheral arterial disease. Atherosclerosis (1999) 1.09
Novel soybean oils with different fatty acid profiles alter cardiovascular disease risk factors in moderately hyperlipidemic subjects. Am J Clin Nutr (2006) 1.09
Ceramide-induced and age-associated increase in macrophage COX-2 expression is mediated through up-regulation of NF-kappa B activity. J Biol Chem (2003) 1.04
Reduction in dietary omega-6 polyunsaturated fatty acids: eicosapentaenoic acid plus docosahexaenoic acid ratio minimizes atherosclerotic lesion formation and inflammatory response in the LDL receptor null mouse. Atherosclerosis (2008) 1.03
Dietary cholesterol and differential monocyte chemoattractant protein-1 gene expression in aorta and liver of apo E-deficient mice. Biochem Biophys Res Commun (2005) 1.02
Enhanced expression of inducible cyclooxygenase with age in murine macrophages. J Immunol (1997) 1.01
The in and out of monocytes in atherosclerotic plaques: Balancing inflammation through migration. Proc Natl Acad Sci U S A (2004) 1.00
Dietary fatty acids and cholesterol differentially modulate HDL cholesterol metabolism in Golden-Syrian hamsters. J Nutr (2005) 0.99
Dietary patterns and the odds of carotid atherosclerosis in women: the Framingham Nutrition Studies. Prev Med (2002) 0.98
Hyperlipidemia is a major determinant of neointimal formation in LDL receptor-deficient mice. Biochem Biophys Res Commun (2006) 0.93
Liver-X-receptor-mediated increase in ATP-binding cassette transporter A1 expression is attenuated by fatty acids in CaCo-2 cells: effect on cholesterol efflux to high-density lipoprotein. Biochem J (2004) 0.90
In vitro fatty acid enrichment of macrophages alters inflammatory response and net cholesterol accumulation. Br J Nutr (2009) 0.88
Glycoxidized low-density lipoprotein regulates the expression of scavenger receptors in THP-1 macrophages. Atherosclerosis (2004) 0.85
Omega-3 fatty acids alter soluble markers of endothelial function in coronary heart disease patients. Nutr Rev (2000) 0.81
Inflammation but not oxidative stress is associated with beta-chemokine levels and prevalence of cardiovascular disease in uraemic patients. Cytokine (2006) 0.80
Time course of systemic markers of inflammation in patients presenting with acute coronary syndromes. Clin Chem Lab Med (2004) 0.78
Nutrition and cardiovascular disease. Eur J Med Res (1997) 0.77
2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol (2013) 17.18
Diet and lifestyle recommendations revision 2006: a scientific statement from the American Heart Association Nutrition Committee. Circulation (2006) 11.65
Nutrition recommendations and interventions for diabetes: a position statement of the American Diabetes Association. Diabetes Care (2008) 9.34
n-3 Fatty acids from fish or fish-oil supplements, but not alpha-linolenic acid, benefit cardiovascular disease outcomes in primary- and secondary-prevention studies: a systematic review. Am J Clin Nutr (2006) 5.43
Systematic review: Vitamin D and cardiometabolic outcomes. Ann Intern Med (2010) 5.36
Interventions to promote physical activity and dietary lifestyle changes for cardiovascular risk factor reduction in adults: a scientific statement from the American Heart Association. Circulation (2010) 3.63
2013 AHA/ACC guideline on lifestyle management to reduce cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation (2013) 3.63
2013 AHA/ACC guideline on lifestyle management to reduce cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol (2013) 3.35
Long-term effects of 2 energy-restricted diets differing in glycemic load on dietary adherence, body composition, and metabolism in CALERIE: a 1-y randomized controlled trial. Am J Clin Nutr (2007) 3.17
Plasma phosphatidylcholine docosahexaenoic acid content and risk of dementia and Alzheimer disease: the Framingham Heart Study. Arch Neurol (2006) 2.98
Effects of omega-3 fatty acids on serum markers of cardiovascular disease risk: a systematic review. Atherosclerosis (2006) 2.56
Dietary recommendations for children and adolescents: a guide for practitioners. Pediatrics (2006) 2.36
Effect of chromium supplementation on glucose metabolism and lipids: a systematic review of randomized controlled trials. Diabetes Care (2007) 2.20
Dietary recommendations for children and adolescents: a guide for practitioners: consensus statement from the American Heart Association. Circulation (2005) 2.16
Effect of soy protein from differently processed products on cardiovascular disease risk factors and vascular endothelial function in hypercholesterolemic subjects. Am J Clin Nutr (2007) 2.15
Antioxidant vitamin supplements and cardiovascular disease. Circulation (2004) 1.76
Meeting adequate intake for dietary calcium without dairy foods in adolescents aged 9 to 18 years (National Health and Nutrition Examination Survey 2001-2002). J Am Diet Assoc (2006) 1.74
Skeletal muscle lipid deposition and insulin resistance: effect of dietary fatty acids and exercise. Am J Clin Nutr (2007) 1.74
Fish intake is associated with a reduced progression of coronary artery atherosclerosis in postmenopausal women with coronary artery disease. Am J Clin Nutr (2004) 1.73
Nutrition recommendations and interventions for diabetes--2006: a position statement of the American Diabetes Association. Diabetes Care (2006) 1.65
Fatty acids in cardiovascular health and disease: a comprehensive update. J Clin Lipidol (2012) 1.59
Adherence to 2005 Dietary Guidelines for Americans is associated with a reduced progression of coronary artery atherosclerosis in women with established coronary artery disease. Am J Clin Nutr (2009) 1.53
Lifestyle intervention reduces body weight and improves cardiometabolic risk factors in worksites. Am J Clin Nutr (2013) 1.52
Plasma antioxidant capacity in response to diets high in soy or animal protein with or without isoflavones. Am J Clin Nutr (2005) 1.51
Cooperation between Polycomb and androgen receptor during oncogenic transformation. Genome Res (2011) 1.47
Curcumin inhibits adipogenesis in 3T3-L1 adipocytes and angiogenesis and obesity in C57/BL mice. J Nutr (2009) 1.47
Treatment of blood cholesterol to reduce atherosclerotic cardiovascular disease risk in adults: synopsis of the 2013 American College of Cardiology/American Heart Association cholesterol guideline. Ann Intern Med (2014) 1.47
Nonnutritive sweeteners: current use and health perspectives: a scientific statement from the American Heart Association and the American Diabetes Association. Diabetes Care (2012) 1.35
Phospho-MED1-enhanced UBE2C locus looping drives castration-resistant prostate cancer growth. EMBO J (2011) 1.33
Systematic review: association of low-density lipoprotein subfractions with cardiovascular outcomes. Ann Intern Med (2009) 1.30
Alterations in cholesterol absorption/synthesis markers characterize Framingham offspring study participants with CHD. J Lipid Res (2009) 1.29
A new species of Lithobius (Monotarsobius) Verhoeff, 1905 (Lithobiomorpha, Lithobiidae) from China. Zookeys (2011) 1.28
New and emerging weight management strategies for busy ambulatory settings: a scientific statement from the American Heart Association endorsed by the Society of Behavioral Medicine. Circulation (2011) 1.27
Eicosapentaenoic acid prevents and reverses insulin resistance in high-fat diet-induced obese mice via modulation of adipose tissue inflammation. J Nutr (2010) 1.26
Understanding the complexity of trans fatty acid reduction in the American diet: American Heart Association Trans Fat Conference 2006: report of the Trans Fat Conference Planning Group. Circulation (2007) 1.25
Extended-release niacin alters the metabolism of plasma apolipoprotein (Apo) A-I and ApoB-containing lipoproteins. Arterioscler Thromb Vasc Biol (2008) 1.25
Comparison of the effects of maximal dose atorvastatin and rosuvastatin therapy on cholesterol synthesis and absorption markers. J Lipid Res (2008) 1.21
Deletion of the phosphoinositide 3-kinase p110gamma gene attenuates murine atherosclerosis. Proc Natl Acad Sci U S A (2007) 1.20
The maximal amount of dietary alpha-tocopherol intake in U.S. adults (NHANES 2001-2002). J Nutr (2006) 1.19
Effect of hydrogenated and saturated, relative to polyunsaturated, fat on immune and inflammatory responses of adults with moderate hypercholesterolemia. J Lipid Res (2002) 1.19
Long-term fatty acid stability in human serum cholesteryl ester, triglyceride, and phospholipid fractions. J Lipid Res (2010) 1.18
Diet-induced obesity and spatial cognition in young male rats. Nutr Neurosci (2008) 1.13
Impact of simvastatin, niacin, and/or antioxidants on cholesterol metabolism in CAD patients with low HDL. J Lipid Res (2003) 1.13
Reduced adiponectin and HDL cholesterol without elevated C-reactive protein: clues to the biology of premature atherosclerosis in Hutchinson-Gilford Progeria Syndrome. J Pediatr (2005) 1.10
Effects of different doses of atorvastatin on human apolipoprotein B-100, B-48, and A-I metabolism. J Lipid Res (2007) 1.10
Palm and partially hydrogenated soybean oils adversely alter lipoprotein profiles compared with soybean and canola oils in moderately hyperlipidemic subjects. Am J Clin Nutr (2006) 1.10
Genetic and environmental influences on factors associated with cardiovascular disease and the metabolic syndrome. J Lipid Res (2009) 1.10
Whole-grain intake and cereal fiber are associated with lower abdominal adiposity in older adults. J Nutr (2009) 1.10
Novel soybean oils with different fatty acid profiles alter cardiovascular disease risk factors in moderately hyperlipidemic subjects. Am J Clin Nutr (2006) 1.09
Nonnutritive sweeteners: current use and health perspectives: a scientific statement from the American Heart Association and the American Diabetes Association. Circulation (2012) 1.09
Independent effects of age-related changes in waist circumference and BMI z scores in predicting cardiovascular disease risk factors in a prospective cohort of adolescent females. Am J Clin Nutr (2010) 1.08
The 2005 USDA Food Guide Pyramid is associated with more adequate nutrient intakes within energy constraints than the 1992 Pyramid. J Nutr (2006) 1.07
Plasma lipid and lipoprotein levels during the follicular and luteal phases of the menstrual cycle. J Clin Endocrinol Metab (2004) 1.07
Cereal fiber and whole-grain intake are associated with reduced progression of coronary-artery atherosclerosis in postmenopausal women with coronary artery disease. Am Heart J (2005) 1.05
Phylloquinone intake and risk of cardiovascular diseases in men. Nutr Metab Cardiovasc Dis (2006) 1.05
Effect of different forms of dietary hydrogenated fats on LDL particle size. Am J Clin Nutr (2003) 1.04
Higher plasma docosahexaenoic acid is associated with reduced progression of coronary atherosclerosis in women with CAD. J Lipid Res (2006) 1.04
Reduction in dietary omega-6 polyunsaturated fatty acids: eicosapentaenoic acid plus docosahexaenoic acid ratio minimizes atherosclerotic lesion formation and inflammatory response in the LDL receptor null mouse. Atherosclerosis (2008) 1.03
Sex hormone modulation of proinflammatory cytokine and C-reactive protein expression in macrophages from older men and postmenopausal women. J Endocrinol (2010) 1.02
Apolipoprotein A-I, B-100, and B-48 metabolism in subjects with chronic kidney disease, obesity, and the metabolic syndrome. Metabolism (2004) 1.01
Serotonin transporter polymorphisms and adverse effects with fluoxetine treatment. Biol Psychiatry (2003) 1.01
A collaborative effort to apply the evidence-based review process to the field of nutrition: challenges, benefits, and lessons learned. Am J Clin Nutr (2007) 1.00
Generalizability of dietary patterns associated with incidence of type 2 diabetes mellitus. Am J Clin Nutr (2009) 1.00
The StrongWomen-Healthy Hearts program: reducing cardiovascular disease risk factors in rural sedentary, overweight, and obese midlife and older women. Am J Public Health (2009) 1.00
Confounding by dietary patterns of the inverse association between alcohol consumption and type 2 diabetes risk. Am J Epidemiol (2009) 1.00
Dietary fatty acids and cholesterol differentially modulate HDL cholesterol metabolism in Golden-Syrian hamsters. J Nutr (2005) 0.99
Effects of omega-3 fatty acids on coronary restenosis, intima-media thickness, and exercise tolerance: a systematic review. Atherosclerosis (2005) 0.99
The role of nutrition in enhancing immunity in aging. Aging Dis (2011) 0.99
Age-associated decline in effective immune synapse formation of CD4(+) T cells is reversed by vitamin E supplementation. J Immunol (2007) 0.99
Approaches to measuring cholesterol absorption in humans. Atherosclerosis (2004) 0.99
Adiponectin: an independent risk factor for coronary heart disease in men in the Framingham offspring Study. Atherosclerosis (2011) 0.97
Interindividual variability and intra-individual reproducibility of glycemic index values for commercial white bread. Diabetes Care (2007) 0.96
Dietary hydrogenated fat increases high-density lipoprotein apoA-I catabolism and decreases low-density lipoprotein apoB-100 catabolism in hypercholesterolemic women. Arterioscler Thromb Vasc Biol (2004) 0.96
Fiber and cardiovascular disease risk: how strong is the evidence? J Cardiovasc Nurs (2006) 0.96
Centrally located body fat is associated with lower bone mineral density in older Puerto Rican adults. Am J Clin Nutr (2011) 0.96
The metabolism of apolipoproteins (a) and B-100 within plasma lipoprotein (a) in human beings. Metabolism (2005) 0.95
Soy protein reduces triglyceride levels and triglyceride fatty acid fractional synthesis rate in hypercholesterolemic subjects. Atherosclerosis (2004) 0.95
Cholesterol absorption and synthesis markers in individuals with and without a CHD event during pravastatin therapy: insights from the PROSPER trial. J Lipid Res (2010) 0.95
Chronic and acute effects of walnuts on antioxidant capacity and nutritional status in humans: a randomized, cross-over pilot study. Nutr J (2010) 0.95
New York City trans fat ban: improving the default option when purchasing foods prepared outside of the home. Ann Intern Med (2012) 0.94
Men and women differ in lipoprotein response to dietary saturated fat and cholesterol restriction. J Nutr (2003) 0.94
Vitamin E and immune response in the aged: molecular mechanisms and clinical implications. Immunol Rev (2005) 0.94
Comparability of methods for LDL subfraction determination: A systematic review. Atherosclerosis (2008) 0.94
Mechanism of vitamin E inhibition of cyclooxygenase activity in macrophages from old mice: role of peroxynitrite. Free Radic Biol Med (2002) 0.93